2012•Nature Reviews Drug DiscoveryRequires access
Brentuximab vedotin
Anas Younes, Uma Yasothan, Peter Kirkpatrick
Open publisher page 168 citations
Abstract
This record does not include an abstract. Use the full-text link above if available.
Anas Younes, Uma Yasothan, Peter Kirkpatrick
Abstract
An abstract is not available in the OpenAlex record for this paper.
OpenAlex reports 168 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Key concepts: Brentuximab vedotin, Antibody-drug conjugate, Food and drug administration, CD30, Medicine, Anaplastic large-cell lymphoma, Lymphoma, Drug